Fabien Ducrocq

Scientific articles

• GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling
  Karlijn L. Kooij, Derek IJsbrand Koster, Emma Eeltink, Mieneke Luijendijk, Lisa Drost, Fabien Ducrocq, Roger A.H. Adan.
  Neuroscience Applied. 2024-01-01. 3 : 103925.
  10.1016/j.nsa.2023.103925